All In Biotech

Free tool

FAERS Monitor: Imbruvica

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 217003 or its brand name (Imbruvica, Ibrutinib). Reports on generic versions are filed under their own applications.

Reports

80,997

Serious

63,021

78% of reports

Hospitalization

26,987

Death reported

13,832

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • death8,652
  • off label use6,069
  • fatigue4,780
  • diarrhoea4,224
  • atrial fibrillation3,926
  • pneumonia3,291
  • contusion2,827
  • incorrect dose administered2,779
  • fall2,544
  • asthenia2,378
  • nausea2,331
  • arthralgia2,226
  • rash2,154
  • haemorrhage2,022
  • disease progression1,999

Reports by year received

View as table
YearReports
20125
201364
20141,286
20154,210
20164,326
20175,376
20187,196
20198,568
202010,342
20217,680
202213,527
20238,225
20244,441
20253,593
20262,158

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,973,162 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
atrial fibrillationSignal3,92610.910.533,899
contusionSignal2,8277.87.516,403
haemorrhageSignal2,0225.14.96,569
disease progressionSignal1,9994.44.35,274
incorrect dose administeredSignal2,7793.23.14,165
pneumoniaSignal3,2912.72.63,415
deathSignal8,6522.62.68,976
fall2,5442.01.91,267
off label use6,0691.81.82,259
diarrhoea4,2241.71.71,258
asthenia2,3781.61.6610
fatigue4,7801.61.61,103
arthralgia2,2261.41.3249
rash2,1541.31.2138
nausea2,3310.80.7176

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.